featured
Conventional Fractionation vs Hypofractionation in Patients With Indications for Proton Postmastectomy Radiotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial
Lancet Oncol 2023 Sep 08;[EPub Ahead of Print], RW Mutter, S Giri, BF Fruth, NB Remmes, JC Boughey, CA Harless, KJ Ruddy, LA McGee, A Afzal, RW Gao, DA Shumway, TZ Vern-Gross, HR Villarraga, SL Kenison, Y Kang, WW Wong, BJ Stish, KW Merrell, ES Yan, SS Park, KS Corbin, CE VargasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.